Illinois Municipal Retirement Fund Acquires New Position in ICU Medical, Inc. (NASDAQ:ICUI)

Illinois Municipal Retirement Fund bought a new position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 12,371 shares of the medical instruments supplier's stock, valued at approximately $1,234,000. Illinois Municipal Retirement Fund owned about 0.05% of ICU Medical as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the company. Private Trust Co. NA increased its stake in shares of ICU Medical by 1,428.6% in the 3rd quarter. Private Trust Co. NA now owns 321 shares of the medical instruments supplier's stock valued at $38,000 after acquiring an additional 300 shares during the last quarter. CWM LLC grew its holdings in ICU Medical by 341.2% during the fourth quarter. CWM LLC now owns 578 shares of the medical instruments supplier's stock valued at $58,000 after purchasing an additional 447 shares during the period. SG Americas Securities LLC acquired a new position in ICU Medical during the fourth quarter valued at approximately $106,000. Knights of Columbus Asset Advisors LLC grew its holdings in ICU Medical by 16.7% during the third quarter. Knights of Columbus Asset Advisors LLC now owns 1,848 shares of the medical instruments supplier's stock valued at $220,000 after purchasing an additional 264 shares during the period. Finally, Xponance Inc. grew its holdings in ICU Medical by 17.8% during the third quarter. Xponance Inc. now owns 2,902 shares of the medical instruments supplier's stock valued at $345,000 after purchasing an additional 439 shares during the period. Institutional investors own 96.10% of the company's stock.

ICU Medical Stock Up 0.3 %

Shares of ICU Medical stock traded up $0.31 on Friday, hitting $94.84. The company had a trading volume of 81,315 shares, compared to its average volume of 193,710. The firm has a market capitalization of $2.31 billion, a P/E ratio of -77.11 and a beta of 0.69. ICU Medical, Inc. has a twelve month low of $78.28 and a twelve month high of $212.43. The company has a debt-to-equity ratio of 0.74, a current ratio of 2.53 and a quick ratio of 1.06. The stock has a 50-day moving average of $101.58 and a 200-day moving average of $97.61.

ICU Medical (NASDAQ:ICUI - Get Free Report) last released its quarterly earnings results on Tuesday, February 27th. The medical instruments supplier reported $1.24 earnings per share for the quarter, beating the consensus estimate of $0.85 by $0.39. The company had revenue of $587.86 million during the quarter, compared to analysts' expectations of $564.77 million. ICU Medical had a negative net margin of 1.31% and a positive return on equity of 6.35%. Research analysts predict that ICU Medical, Inc. will post 3.53 earnings per share for the current year.

Insider Buying and Selling

In related news, VP Daniel Woolson sold 791 shares of the stock in a transaction on Friday, March 15th. The shares were sold at an average price of $98.27, for a total transaction of $77,731.57. Following the completion of the transaction, the vice president now owns 13,980 shares in the company, valued at $1,373,814.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other ICU Medical news, Director George A. Lopez sold 7,978 shares of the company's stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $101.87, for a total transaction of $812,718.86. Following the sale, the director now directly owns 877,343 shares of the company's stock, valued at $89,374,931.41. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Daniel Woolson sold 791 shares of the company's stock in a transaction on Friday, March 15th. The stock was sold at an average price of $98.27, for a total transaction of $77,731.57. Following the sale, the vice president now directly owns 13,980 shares in the company, valued at $1,373,814.60. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 24,262 shares of company stock worth $2,545,532. 6.70% of the stock is owned by insiders.

Analyst Ratings Changes

Separately, KeyCorp boosted their price objective on shares of ICU Medical from $134.00 to $136.00 and gave the company an "overweight" rating in a report on Wednesday, February 28th. One investment analyst has rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $123.00.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.